Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL229846

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCOc1ccc2c(c1)n1ncc(Cl)c1n[n+]2[O-]

Basic Information

ChEMBL ID CHEMBL229846
Phase Preclinical
Structure Type MOL
InChI Key SQSQTHOZZNTUTP-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

264.7
MW (Da)
1.57
ALogP
5
HBA
0
HBD
66.4
PSA (Ų)
0.52
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C11H9ClN4O2
MW 264.67
Aromatic Rings 3
Heavy Atoms 18
NP-Likeness -1.34

Activity Summary

Ki 1 meas. best 6.8

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
Ki 6.8 6.8 160.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked Ki = 160.0 nM 6.8 Displacement of [3H]flumazenil from bovine brain cortex GABAA/Bz receptor 17306981

Literature References

PubMed DOI Target Context # Activities
17306981 10.1016/j.bmc.2007.01.053 Unchecked 1

Data from ChEMBL 36 via Core Engine